Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2015-04-30 AGM Information
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
UCB's shareholder meeting today
AGM Information Classification · 99% confidence The document explicitly states, "UCB held its Annual General Meeting (AGM)" and details the outcomes of that meeting, including dividend approval, director re-appointments, and a summary of the CEO's speech regarding the 2014 performance and 2015 outlook. This content directly corresponds to the purpose of an AGM presentation or summary material. Although it mentions other reports (Annual Report 2014, Interim Report Q1 2015), the primary focus and context of the entire document is the meeting itself. Therefore, the classification should be AGM Information (AGM-R).
2015-04-30 English
Assemblée des actionnaires d’UCB
AGM Information Classification · 98% confidence The document is titled 'Assemblée des actionnaires d'UCB' (UCB Shareholders' Meeting) and details the proceedings, decisions made (like dividend approval), and board elections that occurred during the Annual General Meeting (AGM) on April 30, 2015. It explicitly mentions the CEO's review of 2014 and the 2015 outlook presented at this meeting. This content directly corresponds to the definition of AGM Information.
2015-04-30 French
Algemene vergadering van aandeelhouders UCB
Notice of Dividend Amount Classification · 99% confidence The document is titled 'Algemene vergadering van aandeelhouders UCB' (General Meeting of Shareholders UCB) and details events, decisions (dividend approval, board appointments), and discussions that took place during this meeting. The text explicitly mentions the date of the meeting (April 30, 2015) and refers to the CEO's speech given there. This directly corresponds to the definition of AGM Information (AGM-R). Although it mentions the Annual Report (Jaarverslag 2014) and the Q1 2015 report, the primary focus and context of the entire document is the shareholder meeting itself.
2015-04-30 Dutch
UCB Interim Report for the first three months of 2015
Interim / Quarterly Report Classification · 95% confidence The document is titled 'UCB Interim Report for the first three months of 2015'. It provides detailed financial performance data, including revenue, net sales by product, and regional breakdowns for the first quarter. While it is formatted as a press release, it contains substantive financial data and analysis for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2015
2015-04-30 English
Rapport intermédiaire d'UCB relatif aux trois premiers mois de 2015
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial report for UCB covering the first three months of 2015. It contains detailed financial tables, revenue breakdowns by product and region, R&D updates, and management commentary on financial performance. It is not merely an announcement of a report, but the report itself, containing substantive financial data. Therefore, it is classified as an Interim/Quarterly Report. Q1 2015
2015-04-30 French
Tussentijds verslag UCB voor de eerste drie maanden van 2015
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial update from UCB for the first three months of 2015. It contains detailed financial tables, revenue breakdowns by product and region, and management commentary on financial performance and R&D progress. It is not a mere announcement of a report (RPA) as it provides substantive financial data and analysis. It fits the definition of an Interim/Quarterly Report (IR). Q1 2015
2015-04-30 Dutch

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.